<DOC>
	<DOCNO>NCT01264042</DOCNO>
	<brief_summary>Although essential role iron pregnancy well establish , concern raise current iron supplement give routinely pregnancy may also harmful consequence , increase oxidative stress enhance risk infection , pre-eclampsia impair glucose regulation . A potential mechanism production adverse effect appearance non-transferrin-bound iron oral administration iron supplement . Non-transferrin-bound iron readily available pathogen could promote injurious free radical reaction might add oxidative stress pregnancy . The present study determine oral administration 60 mg iron ferrous sulfate second trimester pregnancy follow appearance non-transferrin-bound iron two hour later . The investigator examine influence variety factor , include iron status previous use iron supplement . Detection non-transferrin-bound iron administration iron supplement pregnant woman would important new observation could lead re-evaluation current method iron supplementation .</brief_summary>
	<brief_title>Iron Supplementation During Pregnancy Non-Transferrin-Bound Iron ( NTBI )</brief_title>
	<detailed_description />
	<criteria>Pregnant woman Age 18 45 year singleton pregnancy 24 28 gestation ( study day ) regular visit prenatal clinic capability willingness comply study protocol voluntary sign informed consent Multiple pregnancy Acute chronic disease disorder Incapability follow study protocol Homelessness Active drug/alcohol dependence abuse history Currently participate another clinical trial participate another clinical trial last 3 month prior begin study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Iron Supplementation ,</keyword>
	<keyword>week 24 28 study day</keyword>
</DOC>